Skip to main content Accessibility help
×
Home

The impact of cancer development on the risk of mycobacterial diseases among rheumatoid arthritis patients

  • S.-W. PAN (a1) (a2) (a3), Y.-F. YEN (a2) (a3) (a4), Y. R. KOU (a5) (a6), P.-H. CHUANG (a7) (a8), J.-Y. FENG (a1) (a2), Y.-J. CHAN (a3) (a9) (a10) and W.-J. SU (a1) (a2)...

Summary

Mycobacterial diseases are prevalent in cancer and rheumatoid arthritis (RA) patients, especially those receiving tumor necrosis factor-α inhibitor (TNFi). However, the impact of cancer development on the risk of mycobacterial diseases among RA patients is unknown. Data from the Taiwan National Health Insurance Research Database were used to conduct a retrospective study to assess the occurrence of mycobacterial diseases in RA patients developing cancer (cancer-positive), those using TNFi (TNFi-exposure), those with cancer and using TNFi (cancer-TNFi-comb), and those without cancer and not using TNFi (cancer-TNFi-free). Cancer and TNFi exposure were time-dependent, and independent risk factors of mycobacterial diseases were assessed by Cox regression. Among 1344 RA patients diagnosed during 2000–2013, 68 (5·1%) developed cancer before their end points. The incidence rates of mycobacterial diseases in the cancer-positive (n = 56), TNFi-exposure (n = 290), cancer-TNFi-comb (n = 12), and cancer-TNFi-free (n = 986) subgroups were 6·7, 2·0, 7·6, and 1·3 per 1000 person-years, respectively. As compared with the cancer-TNFi-free group, the risk for mycobacterial diseases increased for the TNFi-exposure group (adjusted HR = 3·6, 95% confidence interval (95% CI) 1·1–11·5, P = 0·032) and remained high for cancer-positive (adjusted HR = 14·6, 95% CI 3·3–63·7, P < 0·001) after adjustment. This study suggested that cancer development increased the risk of mycobacterial diseases in RA patients, and risk assessment for this subgroup should be considered.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The impact of cancer development on the risk of mycobacterial diseases among rheumatoid arthritis patients
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The impact of cancer development on the risk of mycobacterial diseases among rheumatoid arthritis patients
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The impact of cancer development on the risk of mycobacterial diseases among rheumatoid arthritis patients
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr W.-J. Su, Department of Chest Medicine, Taipei Veterans General Hospital, No. 201, Sec. 2, Shih-Pai Rd., Taipei 11217, Taiwan. (E-mail: wjsu@vghtpe.gov.tw)

References

Hide All
1. World Health Organization. Global Tuberculosis Report. 2014 (http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf).
2. Brode, SK, et al. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. The International Journal of Tuberculosis and Lung Disease 2014; 18: 13701377.
3. Chien, JY, et al. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000–2012. Emerging Infectious Diseases 2014; 20: 13821385.
4. Brode, SK, et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest 2014; 146: 563572.
5. Seo, GH, et al. Cancer-specific incidence rates of tuberculosis: a 5-year nationwide population-based study in a country with an intermediate tuberculosis burden. Medicine (Baltimore) 2016; 95: e4919.
6. Turesson, C, et al. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) 2013; 52: 514.
7. Solomon, DH, et al. Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs. Seminars in Arthritis and Rheumatism 2014; 43: 489497.
8. Simon, TA, et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Research & Therapy 2015; 17: 212.
9. Raheel, S, et al. Risk of malignant neoplasm in patients with incident rheumatoid arthritis 1980–2007 in relation to a comparator cohort: a population-based study. International Journal of Rheumatology 2016; 2016: 4609486.
10. Liao, TL, et al. Risk for mycobacterial disease among patients with rheumatoid arthritis, Taiwan, 2001–2011. Emerging Infectious Diseases 2015; 21: 13871395.
11. Ke, WM, et al. Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan. The International Journal of Tuberculosis and Lung Disease 2013; 17: 15901595.
12. Cantini, F, et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmunity Reviews 2015; 14: 503509.
13. Liao, TL, et al. Different risk of tuberculosis and efficacy of isoniazid prophylaxis in rheumatoid arthritis patients with biologic therapy: a nationwide retrospective cohort study in Taiwan. PLoS ONE 2016; 11: e0153217.
14. Liao, TL, et al. Risk factors and outcomes of nontuberculous mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Scientific Reports 2016; 6: 29443.
15. Wu, CY, et al. The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study. Arthritis Research & Therapy 2014; 16: 449.
16. Arnett, FC, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatology 1988; 31: 315324.
17. Lin, YC, et al. The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study. Clinical Rheumatology 2015; 34: 11951202.
18. Wang, YC, et al. Increased risk of rheumatoid arthritis in patients with migraine: a population-based, propensity score-matched cohort study. Rheumatology International 2017; 37: 273279.
19. Hung, CL, et al. Associated factors for tuberculosis recurrence in Taiwan: a nationwide nested case-control study from 1998 to 2010. PLoS ONE 2015; 10: e0124822.
20. Yeh, JJ, et al. Nontuberculosis Mycobacterium disease is a risk factor for chronic obstructive pulmonary disease: a nationwide cohort study. Lung 2014; 192: 403411.
21. Kamboj, M, et al. The risk of tuberculosis in patients with cancer. Clinical Infectious Diseases 2006; 42: 15921595.
22. Wallis, RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. The Lancet Infectious Diseases 2008; 8: 601611.
23. Smitten, AL, et al. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Research & Therapy 2008; 10: R45.
24. Askling, J, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Annals of the Rheumatic Diseases 2005; 64: 14211426.
25. Wu, CY, et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. The International Journal of Tuberculosis and Lung Disease 2011; 15: 125130.
26. Lai, CC, et al. Nontuberculous mycobacterial infections in cancer patients in a medical center in Taiwan, 2005–2008. Diagnostic Microbiology and Infectious Disease 2012; 72: 161165.
27. Chan, MJ, et al. Compliance with risk management plan recommendations on laboratory monitoring of antitumor necrosis factor-α therapy in clinical practice. Journal of the Formosan Medical Association 2016; 115: 8393.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed